We are live on
!
Find out more
BRA
Bender Robert & Associates Portfolio holdings
AUM
$481M
1-Year Est. Return
35.73%
This Fund
S&P 500
This Quarter
Est. Return
+27.93%
1 Year Est. Return
+35.73%
3 Year Est. Return
+116.09%
5 Year Est. Return
+167.64%
10 Year Est. Return
+1,066.43%
AUM
$481M
AUM Growth
+$64.3M
(+15%)
Cap. Flow
-$5.88M
Cap. Flow
% of AUM
-1.22%
Top 10 Holdings %
Top 10 Hldgs %
74.35%
Holding
46
New
1
Increased
15
Reduced
16
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$170K |
| 2 |
ServiceNow
NOW
|
+$117K |
| 3 |
Microsoft
MSFT
|
+$107K |
| 4 |
Eli Lilly
LLY
|
+$92K |
| 5 |
Palo Alto Networks
PANW
|
+$90.4K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.94M |
| 2 |
Apple
AAPL
|
+$1.43M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$794K |
| 4 |
UroGen Pharma
URGN
|
+$624K |
| 5 |
Pulse Biosciences
PLSE
|
+$263K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.81% |
| 2 | Consumer Discretionary | 16.54% |
| 3 | Healthcare | 14.75% |
| 4 | Communication Services | 13.59% |
| 5 | Industrials | 2.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Costco
COST
$407B
| $1.19M | 0.25% |
1,268
-16
| -1% | -$15.9K |
|
27
Caterpillar
CAT
$361B
| $975K | 0.2% |
916
-8
| -0.9% | -$7.03K |
|
28
Johnson & Johnson
JNJ
$645B
| $819K | 0.17% |
3,224
| – | – |
|
29
JPMorgan Chase
JPM
$926B
| $812K | 0.17% |
2,481
-14
| -0.6% | -$4.35K |
|
30
AbbVie
ABBV
$462B
| $602K | 0.13% |
2,393
| – | – |
|
31
Deere & Co
DE
$184B
| $579K | 0.12% |
912
| – | – |
|
32
Merck
MRK
$359B
| $519K | 0.11% |
4,042
-35
| -0.9% | -$4.1K |
|
33
Nucor
NUE
$58B
| $507K | 0.11% |
2,275
-10
| -0.4% | -$2.26K |
|
34
Gilead Sciences
GILD
$180B
| $356K | 0.07% |
2,819
| – | – |
|
35
Oracle
ORCL
$414B
| $301K | 0.06% |
2,052
| – | – |
|
36
Abbott
ABT
$178B
| $264K | 0.05% |
2,905
| – | – |
|
37
Broadcom
AVGO
$1.65T
| $235K | 0.05% |
622
-48
| -7% | -$19.2K |
|
|
38
Intel
INTC
$520B
| $235K | 0.05% |
+1,680
| New | +$170K |
|
39
Duke Energy
DUK
$92.8B
| $221K | 0.05% |
1,748
| – | – |
|
40
American Electric Power
AEP
$66.6B
| – | – |
-1,900
| Closed | -$249K |
|
41
BioCryst Pharmaceuticals
BCRX
$2.09B
| – | – |
-23,710
| Closed | -$226K |
|
42
Evolus
EOLS
$532M
| – | – |
-25,070
| Closed | -$103K |
|
43
Marriott International
MAR
$88B
| – | – |
-672
| Closed | -$220K |
|
|
44
Pulse Biosciences
PLSE
$3.93B
| – | – |
-12,190
| Closed | -$263K |
|
|
45
UroGen Pharma
URGN
$2.11B
| – | – |
-34,701
| Closed | -$624K |
|
46
Visa
V
$702B
| – | – |
-864
| Closed | -$261K |
|
Similar funds
MA
WAS
SA
NC
HWMG
MAV
OMIC
SCA
Bender Robert & Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Bender Robert & Associates held 46 positions worth $481M, up 15% from $417M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Bender Robert & Associates's Q2 2026 filing shows 1 new, 15 increased, 16 reduced and 7 closed positions. Its largest new stake was Intel: 1,680 shares worth $235K. The largest sale was NVIDIA, an estimated $1.94M.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 44% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Bender Robert & Associates's largest Q2 2026 buy was Intel: 1,680 shares worth $235K.
- Bender Robert & Associates added most to ServiceNow in Q2 2026, an estimated $117K increase.
- Bender Robert & Associates's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.94M.
- Bender Robert & Associates fully exited UroGen Pharma in Q2 2026, selling an estimated $624K.
- Bender Robert & Associates's ten largest holdings make up 74% of its $481M portfolio in Q2 2026.
- Bender Robert & Associates opened 1 new position and closed 7 in Q2 2026.
- Bender Robert & Associates's portfolio value rose 15% quarter-over-quarter to $481M.
Based on Bender Robert & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.